Item 8. Financial Statements and Supplementary Data
ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
BIOMERICA, INC. AND SUBSIDIARIES
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
Report
of Independent Registered Public Accounting Firm (PCAOB ID 0200)
FS-2
– FS-3
CONSOLIDATED
FINANCIAL STATEMENTS
Consolidated Balance Sheets as of May 31, 2024 and 2023
FS-4
Consolidated Statements of Operations and Comprehensive Loss for the Years Ended May 31, 2024 and 2023
FS-5
Consolidated Statements of Shareholders’ Equity for the Years Ended May 31, 2024 and 2023
FS-6
Consolidated Statements of Cash Flows for the Years Ended May 31, 2024 and 2023
FS-7
Notes to Consolidated Financial Statements
FS-8
– FS-20
29
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.